Eisai announces new U.S. cancer research lab
Eisai Co. announced today that the company's U.S. research subsidiary, H3 Biomedicine, held a ceremony on Dec. 1 in Cambridge, Massachusetts, to mark the official opening of its new research facility.
http://ajw.asahi.com/article/economy...AJ201112020054
News Release
EISAI ANNOUNCES COMMENCEMENT OF OPERATIONS OF A NEW RESEARCH
FACILITY AT H3 BIOMEDICINE INC., A U.S. RESEARCH SUBSIDIARY TO FACILITATE
CUTTING-EDGE CANCER GENOMICS-DRIVEN DRUG DEVELOPMENT
-Aims to Provide Personalized Medicine by Integrating
Next-generation Synthetic Organic Chemistry with Patient-Based Cancer Genetics-
http://www.eisai.com/news/news201177.html
Eisai Co. announced today that the company's U.S. research subsidiary, H3 Biomedicine, held a ceremony on Dec. 1 in Cambridge, Massachusetts, to mark the official opening of its new research facility.
http://ajw.asahi.com/article/economy...AJ201112020054
News Release
EISAI ANNOUNCES COMMENCEMENT OF OPERATIONS OF A NEW RESEARCH
FACILITY AT H3 BIOMEDICINE INC., A U.S. RESEARCH SUBSIDIARY TO FACILITATE
CUTTING-EDGE CANCER GENOMICS-DRIVEN DRUG DEVELOPMENT
-Aims to Provide Personalized Medicine by Integrating
Next-generation Synthetic Organic Chemistry with Patient-Based Cancer Genetics-
http://www.eisai.com/news/news201177.html